SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,239,818 | -11.8% | 3,081,307 | 0.0% | 7.97% | -4.3% |
| Q2 2023 | $80,791,870 | +101764.6% | 3,081,307 | 0.0% | 8.32% | -16.1% |
| Q1 2023 | $79,313 | -36.9% | 3,081,307 | -36.2% | 9.91% | -29.4% |
| Q4 2022 | $125,662 | -99.9% | 4,831,307 | 0.0% | 14.04% | -14.6% |
| Q3 2022 | $137,837,000 | +15.9% | 4,831,307 | 0.0% | 16.45% | +17.9% |
| Q2 2022 | $118,947,000 | -56.4% | 4,831,307 | 0.0% | 13.95% | -47.3% |
| Q1 2022 | $272,679,000 | -8.9% | 4,831,307 | 0.0% | 26.48% | +11.5% |
| Q4 2021 | $299,444,000 | -2.3% | 4,831,307 | 0.0% | 23.75% | +24.9% |
| Q3 2021 | $306,498,000 | -36.2% | 4,831,307 | -17.1% | 19.01% | -39.6% |
| Q2 2021 | $480,558,000 | +12.0% | 5,831,307 | 0.0% | 31.49% | +29.6% |
| Q1 2021 | $429,009,000 | -18.8% | 5,831,307 | -19.9% | 24.30% | -26.7% |
| Q4 2020 | $528,040,000 | +52.1% | 7,281,307 | 0.0% | 33.15% | +2.5% |
| Q3 2020 | $347,100,000 | +13.5% | 7,281,307 | 0.0% | 32.35% | +1.0% |
| Q2 2020 | $305,815,000 | +55.6% | 7,281,307 | 0.0% | 32.03% | -3.7% |
| Q1 2020 | $196,595,000 | -29.9% | 7,281,307 | 0.0% | 33.25% | -20.5% |
| Q4 2019 | $280,258,000 | +77.5% | 7,281,307 | 0.0% | 41.80% | +2.8% |
| Q3 2019 | $157,859,000 | – | 7,281,307 | – | 40.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |